7 Results
Position Statement on Medicaid Coverage for Maternal Postpartum Care
Position Statement on Medicaid Coverage for Maternal Postpartum Care
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Position Statement on Screening and Treatment of Mood and Anxiety Disorders During Pregnancy and Postpartum
Use of medication in treating childhood and adolescent depression: Information for patients and families
This revision of the original 2005 Parents Medical Guide to the treatment of depression in children and adolescents is a joint project of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry. It has been updated to include important research that has added to our knowledge about effective treatments for child and adolescent depression. Its goal is to help parents and families make informed decisions about getting the best care for a child with dep
The Management of Depression during Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists
Objective—To address the maternal and neonatal risks of both depression and antidepressant exposure and develop algorithms for periconceptional and antenatal management. Method—Representatives from the American Psychiatric Association, the American College of Obstetricians and Gynecologists and a consulting developmental pediatrician collaborated to review English language articles on fetal and neonatal outcomes associated with depression and antidepressant treatment during childbearing. Ar
Vagal nerve stimulation (VNS) white paper
Vagal nerve stimulation for treatment resistant epilepsy has been available in the United States since 1997, and improved mood noted in epilepsy patients led to studies examining the use of VNS for treatment resistant depression. VNS implantation consists of placement of the stimulator in the chest wall that is attached by wires tunneled through the skin to the left vagus nerve in the carotid sheath. Potential side effects include voice alteration, hoarseness, coughing, paresthesia, dyspnea and
Mental Health and Climate Change
Climate change is recognized as one of the top threats to global health in the 21st century. Mental Health impacts of climate change are significant sources of stress for individuals and communities. The social and mental health consequences of extreme and slow-moving weather events are well documented, ranging from minimal stress and distress symptoms to clinical disorder, including depression, anxiety, post-traumatic stress, and suicidal thoughts (Arnberg et al., 2013; Fullerton et al., 2013;